Introduction
The development of molecular probes for the detection of proteinaceous deposits is of great importance, as the 20 formation of extra-or intracellular protein aggregates is the common pathological hallmark associated with many diseases, including Alzheimer's, Parkinson's and Huntington's disease, and the infectious prion diseases. 1 From a ultrastructural perspective, these protein deposits consist 25 mainly of amyloid fibrils with a diameter of 7-10 nm 2-4 and the detection of these species has for several decades relied on small hydrophobic dyes, such as derivatives of Congo red (CR) [5] [6] [7] and Thioflavin T (ThT). [8] [9] [10] These ligands do not bind to specific proteins but are rather selective towards protein 30 aggregates having an extensive cross β-pleated sheet conformation and a structural regularity 6, 11 , the typical molecular characteristics of presumably all amyloid fibrils. 12, 13 The affinity of CR with a resulting yellow-green birefringence is one of the amyloid criterions 14 but the 35 specificity of CR has been questioned. 15, 16 The information that can be obtained from these conventional probes is also somewhat limited and they cannot be utilized to characterize various conformational entities, such as pre-fibrillar species or heterogenic populations of protein aggregates. It is evident 40 that significant morphological variation can exist between different amyloid fibrils formed from the same peptide or protein and that pre-fibrillar states preceding the formation of well-defined amyloid fibrils are likely to play a critical role in the pathogenesis of protein aggregation diseases. DOI 26 improved the concept and presented defined pentameric structures termed luminescent conjugated oligothiophenes (LCOs) that could be utilized for in vivo imaging of protein 65 aggregates. In comparison with conventional amyloid ligands, LCPs and LCOs have a conjugated thiophene backbone, which brings about a connection between the conformation of the thiophene backbone and its spectral properties. 22, 27 When binding to protein aggregates, the conformation of the 70 backbone is dictated by the protein, which results in conformation-sensitive spectral signatures from the LCP or LCO. 28 LCPs and LCOs have been utilized for staining of thioflavinophilic and congophilic protein aggregates associated with a variety of diseases [21] [22] [23] [24] [25] [26] and also for 75 identifying disease associated protein aggregates that goes undetected with ThT and CR. 23, 26, [29] [30] [31] [32] [33] [34] For instance, LCPs and LCOs have proven very useful for identification of protein aggregates associated with distinct prion strains 26, 29, 31 and for staining of intracelllular inclusion bodies 34 .
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Staining of brain sections from Alzheimer´s disease (AD) patients with the anionic LCO p-FTAA has revealed a spectral discrimination between the two classical pathological hallmarks of AD, amyloid  (A) plaques and neurofibrillary tangles (NFTs) formed of hyperphosphorylated tau protein.
detect non-thioflavinophilic protein assemblies preceeding the formation of amyloid fibrils, as recently reported for p-FTAA 35 , is affected by changing the chemical composition of the LCOs. Herein we report the synthesis of a novel set of anionic oligothiophene probes and the utilization of this 10 library to provide further insight of the basic molecular requirements for achieving an optimal performance of these molecules as ligands for spectral assignment of protein aggregates. 15 
Results and Discussion

Synthesis of Luminescent Conjugated Oligothiophenes
To investigate if and how the length of the thiophene backbone and different chemical substituents affect the 20 performance of LCOs, we synthesized a library of nine LCOs with backbone lengths varying from four to seven thiophenes and with end thiophenes substituted with hydrogen or carboxyl groups at the -position ( Fig. 1 and Fig. 2 ). The synthesis of the thiophene trimer (10) and the three Scheme 2 The synthesis of t-HTAA (1), hx-HTAA (6) and hx-FTAA (7). pentameric oligothiophenes, 15, p-HTAA (4) and p-FTAA (5) have been reported previously.
26, 36 The thiophene trimer 10 is 5 the starting point for the synthesis of tetramers q-HTAA (2) and q-FTAA (3), pentamers p-HTAA (4) and p-FTAA (5), and heptamers h-HTAA (8) and h-FTAA (9) (Scheme 1). Tetrathiophene 19 on the other hand serves as the core building block for tetramer t-HTAA (1) and hexamers hx-10 HTAA (6) and hx-FTAA (7) (Scheme 2). As mentioned above, the LCOs are also varied by having hydrogen or carboxyl groups at the end -positions of the LCOs. These different variants are reffered to as "H"-variants (1, 2, 4, 6 and 8) for the hydrogen substituted ones and "F"-variants (3, 5, 7 15 and 9) for the carboxyl substituted ones. 10 was monobrominated using N-bromosuccinimide (NBS) in DMF at -15°C giving product 11 in 70% yield. The two α-positions of 10 are equal in reactivity as the reaction starts. However, when the first -position has reacted, the reactivity of the 20 second -position drops. Hence, a yield above the statistical 50% can be afforded. The mixture of unreacted starting material, mono-brominated product and di-brominated product was purified on reversed phase. Two other bromination reactions were used during the synthesis. and UV/Vis absorbance (see Supplementary information). However, due to their rather extensive backbones, compound 14, 17 and 22 probably form rather large complexes in most solvents. Therefore, we achieved less resolved NMR spectra of these three compounds, compared to the other molecules.
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Fibrillation of A1-42 and insulin monitored by LCOs
To verify selective binding of the LCOs to protein aggregates, we screened all nine LCOs against ThT positive amyloid fibrils made from recombinant A peptide. All of the 55 LCOs revealed well-resolved excitation and emission spectra with typical shifts in wavelengths when binding to recombinant A fibrils (Fig. 1, Fig. 2 and Table S1 ). These significant changes in the spectral profiles were not seen for LCOs in buffer solution or when mixed with freshly dissolved 60 A1-42. The enhanced emission and the well-resolved spectral substructures most likely arise from a conformationally restricted thiophene backbone 37,38 , due to selective interactions with the Afibrils.
The pronounced shifts (around 50 nm) of the excitation 65 spectra towards longer wavelengths indicate that the LCOs adopt a more extended conformation upon binding to the amyloid fibril resulting in a larger transition dipole moment along the conjugated molecular framework. A variety of studies suggest that other amyloid ligands bind in grooves along the long axis of the amyloid fibril. 11, [39] [40] [41] LCOs are presumably intercalating with the amyloid fibrils through a 10 similar mechanism 42 and the constraints of the fibril binding pocket are inducing unique excitation and emission pathways for the LCO. Hence, the nine LCOs provide distinct optical signatures upon binding to A1-42 fibrils ( Fig. 1 and Fig. 2 ). The development of tools able to identify species preceding the final fibrillar state has lately emerged as crucial, since 10 there is an increasing awareness of these pre-fibrillar species playing an important role in the pathogenesis of misfolding diseases. [17] [18] [19] Recently, Jovin and co-workers 43 A1-42 fibrillation in situ. As we were not able identify prefibrillar species with transmission electron microscopy (TEM) or p-FTAA utilizing our previously reported protocol for A1-42 fibrillation 26 , we tried different fibrillation protocols to achieve reproducible fibrillation kinetic of A1-42 having a 25 prolonged lag phase offering the possibility to observe prefibrillar states preceding the formation of amyloid fibrils. The conditions identified were close to physiological (37 C, 10 mM phosphate buffer supplemented with 14 mM NaCl and 2.7 mM KCl pH 7.4, quiescent) and the concentration of probe was well below the one used for A (0.3 M probe and 10 M A peptide, respectively). When the fluorescence intensity was plotted against time it became evident that a 25 LCO backbone consisting of five or more thiophenes is a prerequisite for detecting non-thioflavinophilic species preceding mature fibrils in the A fibrillation pathway (Fig.  3) . Interestingly, the main difference between the fibrillation protocol reported herein compared to our previously reported 30 protocol 26 is the lack of agitation during fibrillation and it is well-known that shaking can be used as a parameter to induce rapid formation of amyloid fibrils. Hence, the LCO positive pre-fibrillar species of A1-42 is most likely occurring as a consequence of slowing down the formation of amyloid fibrils 35 as this species could not be observed for p-FTAA when agation was used during fibrillation 26 .
The kinetic profile monitored by the tetrameric probes t-HTAA, q-HTAA and q-FTAA revealed an onset of 40 fibrillation around 300 minutes after initiation (Fig. 3a) . The kinetic curves were similar to the one obtained with ThT when it came to length of lag phase and fibrillation onset, however, the tetramers reached the plateau phase more rapidly than ThT. The resemblance with ThT was rather expected due to 45 the structural similarity. When the backbone was extended with one thiophene residue, the effect on the detection capacity was obvious. Both p-HTAA and p-FTAA revealed an A1-42 fibrillation process with a growth phase initiated around 60 minutes, which was 300 minutes earlier than ThT hence the earlier growth phase monitored by LCOs was not caused by the probes accelerating the kinetics ( Supplementary  Fig. S1 ). In addition, kinetic experiments under identical conditions (37 C, 10 mM phosphate buffer supplemented with 14 mM NaCl and 2.7 mM KCl pH 7.4, quiescent) having only the pentameric, hexameric and heptameric LCOs present or the LCOs mixed with 100 M bovine serum albumin (BSA) or 10 M bovine insulin (BI) were also performed. To our knowledge, these proteins will not form protein aggregates under this condition. All LCOs, except hx-HTAA, 5 showed identical spectra throughout the experiments (1020 minutes) compared with time point 0 minutes, verifying that the characteristic spectroscopic signature obtained from these LCOs during the kinetic measurements of A 1-42 fibrillation is associated with pre-fibrillar and fibrillar aggregated species 10 of A 1-42 ( Fig. S2) . For hx-HTAA we observed a slight decrease of the spectral intensity over time when the dye was free in solution, whereas the opposite occurred when the dye was mixed with BSA ( Fig. S2i and S2l). However, the spectrum was unaffected over the same time period when 15 mixed with BI and under none of these experiments we were able to obtain a spectroscopic signature similar to the one observed for hx-HTAA interacting with pre-fibrillar and fibrillar aggregated species of A 1-42 ( LCOs might occur due to solubility problems of hx-HTAA, as this dye has only two negatively charged side chain functionalities on a hexameric thiophene backbone and hx-HTAA is therefore deemed less suitable for performing kinetic measurements than the other LCOs. 25 It is well known that the formation of amyloid fibrils is a rather complex event. The simultaneous occurrence of different aggregate species in solution and involvement of heterogeneous aggregation mechanisms render it possible that the LCOs detect the existence of non-fibrillar aggregates 30 occuring in competition with the formation of amyloid fibrils during the A aggregation pathway. Therefore, we utilized the pentameric, hexameric and heptameric LCOs to monitor fibrillation kinetics of BI under acid conditions, as it was recently shown that insulin under the conditions used, 35 assembled into amyloid-fibrils through a hexameric oligomer unit. 44 Similar to the results from the A1-42 kinetics, all LCOs detected early non-thioflavinophilic species of insulin and optical density (OD) measurements verified that the LCOs did not affect the fibrillation rate ( Supplementary Fig. S3 and 40 S4).
The detection of non-thioflavinophilic Aand insulin species by pentameric, hexameric or heptameric LCOs, might be explained by the extended thiophene backbone enhancing the affinity of the LCOs towards these aggregated species. 45 Qin et al. recently reported a similar observation for a dimeric version of ThT. 45 However, as described above, the mechanism by which ThT and other amyloid ligands recognize fibrillar structures are still poorly understood. In addition of binding, ThT also needs to be sterically locked in 50 order to fluoresce, since free rotation around the benzylamine and benzathiole rings quenches the excited states of ThT. [46] [47] [48] Hence, it is possible that ThT and the tetrameric LCOs are capable of binding to the early states seen in the A1-42 and insulin fibrillation, but in their "quenched" mode. Further 55 elongation of the fibrils and more ordered structures might cause the immobilization of the ThT molecule that is necessary for the dramatic increase in fluorescence seen at the later stages of the kinetic experiment. In contrast, the pentameric, hexameric and heptameric LCOs seem to adopt a 60 sterically locked conformation giving rise to a highly fluorescent mode of these LCOs when interacting with protein assemblies preceeding the formation of amyloid fibrils. In fact ,the plateau phase of pentameric and longer LCOs coincided with the initiation of growth phase monitored by ThT, 65 supporting the theory that ThT needs more ordered fibrils in order to fluoresce. The fluorescence of all investigated LCOs decayed after the plateau phase was reached, which indicated increased stacking of probes due to more densely organised amyloid fibrils. Alternatively different conformations of the 70 LCOs when bound to the early formed assemblies compared to mature fibrillar states could be invoked to explain these observations, However, both the excitation-and emission spectral profiles of the LCOs bound to these species are similar, suggesting that the LCOs bind in a analogous fashion 75 to early formed assemblies and mature fibrils. Nevertheless, it is well established that the LCO p-FTAA fluoresce very strongly when bound to mature amyloid fibrils in tissue ( that Japanese mutant A rapidly formed amyloid fibrils that were only weakly stained by ThT. 49 So far we can only speculate about the nature of the LCO positive protein assemblies preceding amyloid fibril formation. These assemblies might be fibrillar or non-fibrillar aggregates 100 formed on the A aggregation pathway or in competition with the formation of amyloid fibrils. However, the excitation-and emission spectra from the pentameric, hexameric and heptameric LCOs bound to the pre-fibrillar protein assemblies or to mature amyloid fibrils are similar, suggesting that these 
Spectral signatures of LCOs binding to protein aggregates in human AD brain tissue
We have previously reported that p-FTAA can be used to spectrally discriminate between A plaques and NFTs in frozen brain sections from AD patients. 26 Since this spectral (excitation: 535 or 546 nm) long pass filters were utilized to record a complete emission spectral profile of the LCOs. A plaques and NFTs were identified due to their well-known characteristic morphology seen with antibody staining (Supplementary Fig. S5 ).
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All the tetrameric LCOs (t-HTAA, q-HTAA and q-FTAA) specifically stained both A plaques and NFTs in AD affected regions.
Moreover, the probes also highlighted cerebrovascular amyloid deposits and dystrophic neurites, two other well-known pathological markers of this disease. All 60 tetramers displayed well-resolved emission spectra upon binding to amyloid deposits, but there was no significant spectral distinction between A and tau deposits when using two different long pass filters (excitation at 405 or 436 nm) ( Supplementary Fig. S6 ). The tetrameric LCOs showed no significant emission when using a long pass filter for longer wavelengths (excitation: 535 or 546 nm). It also became evident that the tetrameric probes tended to photobleach, 5 which was indicated by the change of the normally blueshifted emission spectra against longer wavelengths upon prolonged exposure of light.
In accordance with previous results 26 , LCOs having a pentameric thiophene backbone (p-HTAA and p-FTAA) 10 displayed selective binding towards protein aggregates and these pathological hallmarks were also specifically stained by LCOs having a hexameric (hx-HTAA and hx-FTAA) (Fig. 4) or a heptameric thiophene backbone (h-HTAA and h-FTAA) (Fig. 5) . Similar to the tetrameric LCOs, all longer LCOs 15 showed well-resolved emission spectra upon binding to A or tau deposits using blue (excitation: 405 nm) or green (excitation: 470 or 480 nm) long pass filters. Secondly, these LCOs also exhibited a substantial amount of emission at longer wavelengths when a red long pass filter was used 20 (excitation: 535 or 546 nm) (Fig. 4 and Fig. 5) . A red-shift of the emission maxima was observed as the electronic conjugation length of the thiophene backbone was extended and the "F" variants always showed more reddish spectra compared to their "H" counterparts mainly due to extension of 25 the conjugated thiophene backbone by carboxyl groups. Interestingly, the difference in spectral shift was most pronounced when comparing p-FTAA with p-HTAA, indicating that the maximum effect of the carboxyl moieties on the electronic system is obtained with a pentameric 30 thiophene backbone.
When examining the spectral differences for A plaques and NFTs, the pentameric, hexameric and heptameric "F" variants showed a clear difference in the overall appearance of the emission spectra (excitation: 405, 470 or 480 nm) for these 35 pathological hallmarks, whereas this spectral difference was not observed for the "H" counterparts ( Fig. 4 and Fig. 5) . Binding of the "F" variants to aggregated tau in NFTs and dystrophic neurites displayed increased contribution of redshifted wavelengths compared to the spectra from A plaques. 40 This was evident from the disappearance of the most blue shifted peak and a more pronounced shoulder at longer wavelengths (Fig. 4 and Fig. 5) . By exciting the LCOs at 405 nm and 535/546 nm and then merging the resulting emission spectra, the spectral difference became even more evident, 45 since this operation highlights both green and red contributions to the spectrum. When plotting the ratio of the intensity of the emitted light at the blue shifted and red shifted emission maxima (Fig. 4 and Fig 5) , there was a clear separation between A and tau aggregates proving the 50 discrepancy in emission from the "F" variants upon binding to the respective pathological entity. The merged emission spectrum of one of the "H" variants, hx-HTAA, also revealed a distinction in color between the protein aggregates. The spectra from tau deposits were green-shifted compared to the 55 spectra observed from Aplaques, a result that was opposite that of the "F" variants. The ratio plot showed a rather wide distribution of the tau aggregates and a partly overlap between the two pathological hallmarks (Fig. 4n) .
When the ratio plots were compared, it became evident that 60 the "F" variants were superior LCOs for spectral distinction of the two pathological hallmarks seen in AD. Secondly, p-FTAA surpassed both hx-FTAA and h-FTAA, again showing that the maximum effect of the carboxyl extentions on the electronic system was obtained having a pentameric 65 thiophene backbone. Although, it is evident that the carboxyl groups are crucial to obtain a spectral difference between A and tau deposits, the spectral observations cannot explain the difference between these two protein aggregates on a molecular basis. that the polymeric LCP PTAA was incapable of spectrally discriminating A and tau deposits in human tissue 26 also indicates that the underlying molecular mechanism of the spectral signature from p-FTAA, hx-FTAA and h-FTAA might not be dependent on conformational differences 85 between A and tau deposits. Instead, the red-shift in emission might arise from interplay between the end carboxyl groups extending the LCO backbone and chemical groups in the binding pocket of tau aggregates. Tau aggregates are known to carry a diverse array of chemical modifications 50 , 90 including extensive phosphorylations, and these modifications might affect the conjugation system causing the observed redshift of the emission.
Conclusions
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In conclusion, we have shown that certain molecular requirements are necessary for achieving an anionic oligothiophene based ligand capable of detecting nonthioflavinophilic aggregated species preceeding amyloid fibril formation and for obtaining distinct spectral signatures of the 100 two main pathological hallmarks observed in AD. Preferably, such a ligand should have a backbone consisting of five to seven thiophene units and carboxyl groups extending the conjugated thiophene backbone. The addition of such LCOs to the toolkit of fluorescent ligands will be important for 105 studying the underlying molecular events of protein aggregation disease and for obtaining sensitive diagnostic tools for these diseases.
Experimental
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General methods
Organic extracts were dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo at 40 ºC. 51 Thin layer chromatography (TLC) was carried out on Merck precoated General procedure A: Suzuki coupling with a thiopheneboronic acid and a mono-or dibrominated oligothiophene. 35 To a solution of the brominated oligothiophene (1 mmol) in toluene/methanol (1:1, 5 mL, degassed) K 2 CO 3 (3 eq./bromine), the desired thiophene boronic acid (2 eq./bromine) and PEPPS-IPr (0.02 eq.) were added. The mixture was heated to 70 °C for 15 minutes. Whereupon 40 work-up followed.
General procedure B: Dibromination of an oligothiophene
To a solution of the oligothiophene (1 mmol) in DMF (5 mL, -15 °C) NBS (2 mmol) was added slowly whereupon the reaction reached room temperature. After 2h, the reaction was 45 diluted with toluene, washed with HCl (1M, aq.) twice and brine three times.
General procedure C: Suzuki coupling with a diboronic acid or ester with a monobrominated oligothiophene.
The desired boronic derivative (1 mmol), the monobrominated 50 oligothiophene (3 mmol), K 2 CO 3 (4 mmol) and PEPPSI-IPr (0.02 mmol) were dissolved in degassed toluene/methanol (1:1, 5 mL) and heated to 70 °C for 15 minutes. Whereupon work-up followed.
General procedure D: Hydrolysis methylesters.
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To a solution of the oligothiophene (1 mmol) in dioxane (10 mL) NaOH (1M, 1.5 eq/acid and ester) was added. When precipitation started, H 2 O (10 mL) was added. When only product was seen on MS, the reaction was lyophilized and stored under refrigerated, dark conditions.
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Synthesis of t-HTAA (1)
General procedure D was applied to compound 19 to give the product t-HTAA (1) 
Synthesis of q-FTAA (3)
General procedure D was applied to compound 13 to give the product q-FTAA ( 
Synthesis of hx-HTAA (6)
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General procedure D was applied to compound 21 to give the product hx-HTAA (6) 
Synthesis of hx-FTAA (7)
General procedure A was applied to 20 and 5-(dihydroxyboryl)-2-thiophenecarboxylic acid. After the reaction, the mixture was acidified with acetic acid, diluted with ethyl acetate and washed three times with H 2 O and subjected to normal work-up. The crude product was recrystallized from dixone to give 22 (82%) as a red powder. General procedure D was applied to 22 to afford the product hx-FTAA (7) 124.2, 124.6, 126.4, 129.3, 131.9,  132.3, 133.9, 134.2, 134.6, 136.4, 139.3, 140.9, 169.8, 179.3 .
Synthesis of h-HTAA (8)
General procedure C was applied to 11 and thiophene-2,5-diboronoic acid. After the reaction, the solution was decanted 15 and evaporated to relative dryness. The remaining portion in the reaction vessel, containing salts, was repeatedly washed with EtOAc (5 × 20 mL) and combined with the mother liquor, which was then washed with water (2 × 50 mL), then 1M HCl solution (2 × 50 mL). The organic phase was dried 20 over MgSO 4 , filtered and evaporated to dryness. The solid was slurried in ethanol, filtered and dried under vacuum giving the compound 14 (99 %) as an amorphous orange/red powder. General procedure D was applied to 14 to afford the prodcut h-HTAA (8) 
Synthesis of h-FTAA (9)
General procedure A was used with 5-(dihydroxyboryl)-2-thiophenecarboxylic acid and 16. After the reaction was 35 finished, the solution was decanted and evaporated to relative dryness. The remaining portion in the reaction vessel, containing salts, was repeatedly washed with EtOAc (5 × 20 mL) and combined with the mother liquor, which was then washed with water (2 × 50 mL), then 1M HCl solution (2 × 50 
Synthesis of product 11
NBS (2.35 g, 13.2 mmol) was added to solution of 10 (5.36 g, 13.7 mmol) dissolved in DMF (100 mL) at -15°C, afterwhich the stirring solution was allowed to achieve room temperature 55 and stir for a further hour. When TLC and MALDI-TOF MS indicated that the reaction was complete the mixture was diluted with toluene and washed with brine and water before being subjected to normal work-up. The product was purified on reversed phase (acetonitrile/water (30: 
Synthesis of product 12
General procedure A was used with 11 and 2-thiopheneboronic acid. After the reaction, the product was purified by FC (toluene) to afford compound 12 (92 %) as a yellow powder. 
Synthesis of 13
General procedure A was used with 11 and 5-(dihydroxyboryl)-2-thiophenecarboxylic acid. After the reaction, acetic acid and ethyl acetate were added to the reaction mixture. 
Synthesis of product 16
General procedure B was applied to compound 15. 
Synthesis of product 18
3-thiopheneacetic acid (14.2 g, 100 mmol) was dissolved in 10 diethyl ether (150 mL, dry) and cooled to 0 °C. Thionylchloride (15.8 mL, 300 mmol) was added slowly. After 1 h, the solution was evaporated, dissolved in diethyl ether (150 mL, dry) and cooled in an ice bath. Methanol (dry, excess) was added slowly to the solution and allowed to stir at 15 room temperature for 1 h. The solvents were evaporated while the product was redissolved in ethyl acetate and washed with NaHCO 3 (sat. aq.) followed by water. The methyl ester of 3-thiopheneacetic acid was dissolved in chloroform/acetic acid (4:1, 180 mL) and NBS (17.8 g, 100 mmol) was added 20 portionwise over two hours. 
Synthesis of product 19
General procedure C was used with 18 and 2,2′-Bithiophene-5,5′-diboronic acid bis(pinacol) ester. After the reaction the solution was diluted with toluene and washed with HCl (1M, 35 aq.) twice and brine 3 three times. The product was purified by FC (toluene) to give compound 19 (85%) as yellow oil. Rf: 0. 42 for t-HTAA, q-HTAA and q-FTAA were collected between 470-640 nm with excitation wavelength 430 nm. The emission spectra for p-HTAA and p-FTAA were collected between 480-650 nm with excitation wavelength 450 nm. The emission spectra for hx-HTAA, hx-FTAA, h-HTAA and h-FTAA were 90 collected between 500-670 nm with excitation wavelength 480 nm. ThT was excited at 430 nm (emission between 470-640 nm) when used as a reference for the tetramers and it was excited at 450 nm (emission between 480-650 nm) when used as a reference for the pentamers, hexamers and heptamers. All 95 samples were done in triplicates. Experiments replacing the A1-42 peptide with 10 M bovine serum albumin (MP Biomedicals, Solon, USA) or 100 M bovine insulin (I6634, Sigma Aldrich) were also performed in a similar fashion.
Excitation spectra for the LCOs were obtained at time point 100 0 minutes (right after the addition of soluble A1-42) and for probes binding to A1-42 fibrils (at the plateau phase). The excitation spectra for t-HTAA (emission at 490 nm), q-HTAA (emission at 490 nm), q-FTAA (emission at 505 nm) and p-HTAA (emission at 490 nm) were collected between 270-470 105 nm. The excitation spectra for p-FTAA (emission at 507 nm), hx-HTAA (emission at 522 nm), hx-FTAA (emission at 535 nm), h-HTAA (emission at 538 nm) and h-FTAA (emission at 548 nm) were collected between 300-500, 310-510, 325-525, 335-535 nm, respectively. PBS were also obtained using the same settings as described above. Amyloid fibrils of bovine insulin were prepared according to a previously reported protocol 29, 38 . In brief, a stock solution containing 5 mg mL -1 bovine insulin (I6634, Sigma 5 Aldrich) in 2 M acetic acid supplemented with 500 mM NaCl was placed in a water bath kept at 50 C to induce formation of amyloid-like insulin fibrils. Aliquots of 100 μL were withdrawn at different time points and mixed with 2 μL of the LCO stock solution (15 μM) or 2 μL of a ThT stock solution 10 (15 μM). The fibrillation was also performed having 300 nM of LCO present during the fibrillation event. The samples were prepared in micro-titer plates and incubated for 10 min at room temperature. The emission spectra were recorded as described above.
LCO staining and spectral analysis
Cryosections (20 m) of human brain tissue with AD pathology were fixed with ice cold acetone for 10 min at -20°C and then allowed to dry. The sections were incubated 20 with PBS for 10 min and then stained for 30 min at RT with t-HTAA, q-HTAA, q-FTAA, p-HTAA, p-FTAA, hx-HTAA, hx-FTAA, h-HTAA or h-FTAA. All probes were diluted 1:500 in PBS from a 1.5 mM stock. After rinsing with PBS three times, the sections were mounted with Dako The emission profile of each LCO was obtained by collecting the emission spectrum for 7-8 regions of interest in five A plaques and five tau tangles, respectively, using the above 40 mentioned excitation wavelengths and the same exposure time for the two protein entities. Computational analyzes were performed with the SpectraView 3.0 EXPO software (Applied Spectral Imaging), which is a program that renders it possible not only to obtain emission spectra for each excitation 45 wavelength but also to merge two different excitations into one resulting emission spectrum. This operation was performed after exciting p-FTAA, hx-FTAA, h-HTAA and h-FTAA at 405 and 546 nm, and hx-HTAA at 405 and 535 nm. The same thing could 50 not be done with t-HTAA, q-HTAA, q-FTAA or p-HTAA since their emission at 535 or 546 nm was almost nonexisting. The double-excitation emission spectra were used to do ratio plots for each LCO and determine their capability to spectrally separate A plaques and tau tangles. 
